Science Current Events | Science News | Brightsurf.com
 

Therapeutic Cloning Current Events | Therapeutic Cloning News | 9
Page 9 of 14 | 335 Results
Previous0405060708091011121314   Next   
Sort By: Page Views | Date
Imprint's DepotOne needle achieves CE Mark
Imprint Pharmaceuticals (www.imprintpharma.com) is pleased to announce that its DepotOne needle technology has received its CE Mark and is now cleared for use in Europe. This CE Approval means that the DepotOne needle can be incorporated into clinical studies and existing products with minimal... view more (2004-10-11)

Green tea compound may be a therapy for people with rheumatoid arthritis
A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.   view more (2007-04-30)

Sildenafil prevents rebound pulmonary hypertension in infants
A single dose of sildenafil, a blood vessel widening vasodilator, prevented rebound pulmonary hypertension and significantly reduced the duration of mechanical ventilation in intensive care unit (ICU) infants being withdrawn from inhaled nitric oxide therapy.   view more (2006-11-01)

UI Researchers Studying Novel Therapy For Prostate Cancer
A team of University of Iowa Health Care researchers has launched an important clinical trial of a novel therapeutic that may eventually lead to new treatments for men diagnosed with prostate cancer.   view more (2006-10-16)

Diet and lifestyle critical to recovery, says study
Diet and lifestyle may play a much more significant role in a person's ability to respond favourably to certain drugs, including some cancer therapies, than previously understood, say scientists.   view more (2008-01-18)

First calves from gene diagnosed embryos born at MTT Agrifood Research Finland
Results from quantitative trait gene mapping (QTL) have been utilised for the first time in the selection of bovine embryos. The genotypes of two genes affecting milk yield and composition have been analysed from pre-implantation embryo biopsies. The first four female calves with known milk... view more (2003-08-14)

New Combination Therapy Could Reduce Ischaemia After Heart Attack (p 605)
Encouraging results from a fast-track study published in this week's issue of THE LANCET suggest a new therapeutic strategy for reducing ischaemic complications (coronary artery blockage) after heart attack. The treatment of acute heart attack requires combination of several therapies. Fibrinolytic... view more (2001-08-22)

Research News From BBSRC
* New approach to selective killing of tumour cells A new protein-based system offers a potential strategy for molecular cancer therapy without the need for viral or DNA vectors. It uses natural peptides, capable of transporting material through membranes, and a viral protein that induces cancer... view more (2004-04-02)

For Stanford scientists, RNAi gene therapy takes two steps forward, one step back
Three years ago Mark Kay, MD, PhD, published the first results showing that a hot new biological phenomenon called RNA interference was an effective gene-therapy technique in mice.   view more (2006-05-25)

EMBO supports researchers from emerging economies
The first fellows benefiting from the European Molecular Biology Organization's (EMBO) new World Programme fellowship scheme will start their work in their guest laboratories from now on. The four selected researchers come from Bangladesh, Brazil, Cuba and India and will visit German or Israeli... view more (2002-11-08)

Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
Researchers at Jefferson's Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer's growth.   view more (2008-02-28)

Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy
Inhibitors of cyclooxygenase-2 (COX-2) were developed to relieve inflammatory pain as effectively as nonsteroidal anti-inflammatory drugs (NSAIDS), but without one of their major side effects, gastrointestinal bleeding.   view more (2006-04-14)

Early Promise For Dementia Drug (pp 1265, 1283)
Encouraging short-term results of a randomised trial in this week's issue of THE LANCET suggest that the drug galantamine could offer therapeutic benefits to people with Alzheimer's disease with cerebrovascular disease and in those with probable vascular dementia. Vascular dementia-dementia caused... view more (2002-04-10)

Low-sodium advice for asthmatics should be taken with a pinch of salt
Following a low-sodium diet does not appear to have any appreciable impact on asthma control, according to new research.   view more (2008-07-16)

More evidence of cannabis-induced psychosis: Cannabis-based medicines given in a highly-controlled clinical environment unexpectedly lead to strong psychotic effects
Volunteers taking cannabis-based therapeutic drugs as part of a controlled trial, which had been approved by an ethics board as safe for the subjects, experienced psychotic effects just as strong as if they had smoked cannabis. These findings, highly unexpected in such a controlled environment, are... view more (2005-03-30)

Against pulmonary fibrosis
The biotech companies Digna Biotech and Biotherapix have signed an agreement to jointly apply their patented products towards the development of a treatment for pulmonary fibrosis.   view more (2006-03-06)

Greasing interferon's gears may pave way to greater therapeutic benefits, fewer side effects
Interferon - a critical protein that mediates the body's defense against a wide variety of infectious agents and tumors - may soon have greater therapeutic value.   view more (2005-10-03)

University of Sydney researchers find new evidence linking kava to liver damage
In recent years, serious concerns about the dangers of kava and the effects on the liver have resulted in regulatory agencies, such as the US Food and Drug Administration and Australia's Therapeutic Goods Administration, banning or restricting the sale of kava and kava products.   view more (2008-02-25)

Chemistry & Industry Issue 2 - Cover Date Monday 21 January 2002
NEWS   view more (2002-01-16)

A New Startup Fund Called EMERTEC
CEA (the French Atomic Energy Commission) and the Caisse des Dépôts et Consignations (CDC) promoted the setup of EMERTEC, a new startup fund for investing in new high technology companies on emerging, booming markets. The shares issue has been open since January 2000 and has already... view more (2000-06-20)

One therapeutic dose of radiation causes 30 percent spongy bone loss in mice
Mice receiving just one therapeutic dose of radiation lost up to 39% of the spongy portion of their inner bone, reducing the inner bone's weight bearing connections by up to 64%, researchers reported.   view more (2006-07-13)

DNA research taking guesswork out of finding the 'therapeutic window'
It's only spit, but what's inside your saliva may help solve a dosing dilemma facing doctors and patients.   view more (2008-10-24)

ESC Congress 2003: Preferred treatment of angina (chest pain)
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: We have shown that in European and... view more (2003-09-01)

BULIMIA DOES NOT APPEAR OUT OF A CLEAR SKY
There are a lot of publications dealing with the characteristics of bulimia nervosa. However, there was pratically no literature on how bulimia nervosa develops. In the first investigation on the prodromal phase (what takes place in the six months prior to the onset of bulimic symptoms)of bulimia... view more (2000-09-19)

Yale scientists show that a microRNA can reduce lung cancer growth
A small RNA molecule, known as let-7 microRNA (miRNA), substantially reduced cancer growth in multiple mouse models of lung cancer, according to work by researchers at Yale University and Asuragen, Inc., published in the journal Cell Cycle.   view more (2008-03-24)
Page 9 of 14 | 335 Results
Previous0405060708091011121314   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com